A detailed history of Crestwood Advisors Group LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Crestwood Advisors Group LLC holds 186,031 shares of EW stock, worth $12.6 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
186,031
Previous 217,911 14.63%
Holding current value
$12.6 Million
Previous $20.1 Million 39.01%
% of portfolio
0.24%
Previous 0.42%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$59.7 - $93.78 $1.9 Million - $2.99 Million
-31,880 Reduced 14.63%
186,031 $12.3 Million
Q2 2024

Aug 01, 2024

SELL
$84.3 - $94.31 $133,194 - $149,009
-1,580 Reduced 0.72%
217,911 $20.1 Million
Q1 2024

May 08, 2024

SELL
$72.54 - $95.56 $127,380 - $167,803
-1,756 Reduced 0.79%
219,491 $21 Million
Q4 2023

Jan 29, 2024

SELL
$61.71 - $77.76 $125,209 - $157,775
-2,029 Reduced 0.91%
221,247 $16.9 Million
Q3 2023

Nov 15, 2023

BUY
$69.28 - $93.38 $15.5 Million - $20.8 Million
223,276 New
223,276 $15.5 Million
Q2 2022

Jul 07, 2022

SELL
$86.5 - $128.27 $158,208 - $234,605
-1,829 Closed
0 $0
Q1 2022

Apr 12, 2022

SELL
$101.96 - $128.34 $33,137 - $41,710
-325 Reduced 15.09%
1,829 $215,000
Q4 2021

Feb 15, 2022

BUY
$106.37 - $130.68 $229,120 - $281,484
2,154 New
2,154 $279,000
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $1.23 Million - $1.89 Million
-23,375 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$71.7 - $82.09 $153,796 - $176,083
-2,145 Reduced 8.41%
23,375 $5.45 Million
Q3 2019

Nov 13, 2019

SELL
$61.55 - $75.43 $92,940 - $113,899
-1,510 Reduced 5.59%
25,520 $5.61 Million
Q2 2019

Aug 14, 2019

BUY
$55.74 - $64.41 $1.51 Million - $1.74 Million
27,030 New
27,030 $4.99 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Crestwood Advisors Group LLC Portfolio

Follow Crestwood Advisors Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestwood Advisors Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crestwood Advisors Group LLC with notifications on news.